- Joined
- Oct 20, 2013
- Messages
- 24,883
- Reaction score
- 10,597
- Location
- daily dukkha
- Gender
- Male
- Political Leaning
- Undisclosed
also very useful for end of life treatment ( aftereffects are reduced anxiety about dying)
www.washingtonexaminer.com
Australia legalized and regulated MDMA and psilocybin mushrooms, and the country will begin allowing prescriptions starting July 1.
Doctors will only be able to prescribe MDMA, otherwise known as ecstasy, to patients attempting to treat post-traumatic stress disorder and psilocybin mushrooms to patients who have experienced treatment-resistant depression. Every prescribing psychiatrist must obtain approval from a Human Research Ethics Committee out of the National Health and Medical Research Council.
Psilocybin, as it is found in mushrooms, is a relatively cheap drug, but it requires a "treatment protocol involving assessment and on-going psycho-therapeutic management by the psychiatrist before and after administration of appropriately supervised single dosing of the patient in an appropriate setting (such as a day hospital or an inpatient setting)," which could contribute to the treatment cost.
The Center for Psychedelic and Consciousness Research at Johns Hopkins University has conducted extensive research into psilocybin as a treatment for depression, anxiety, and nicotine addiction.
Colorado and Oregon have also legalized psilocybin mushrooms, and a handful of other cities have passed local measures decriminalizing some psychedelics, including Denver and Washington, D.C.
Australia becomes first country to legalize psychedelics - Washington Examiner
Australia legalized and regulated MDMA and psilocybin mushrooms, and the country will begin allowing prescriptions starting July 1. Doctors will only be able to prescribe MDMA, otherwise known as ecstasy, to patients attempting to treat post-traumatic stress disorder and psilocybin mushrooms to...
www.washingtonexaminer.com
Doctors will only be able to prescribe MDMA, otherwise known as ecstasy, to patients attempting to treat post-traumatic stress disorder and psilocybin mushrooms to patients who have experienced treatment-resistant depression. Every prescribing psychiatrist must obtain approval from a Human Research Ethics Committee out of the National Health and Medical Research Council.
Psilocybin, as it is found in mushrooms, is a relatively cheap drug, but it requires a "treatment protocol involving assessment and on-going psycho-therapeutic management by the psychiatrist before and after administration of appropriately supervised single dosing of the patient in an appropriate setting (such as a day hospital or an inpatient setting)," which could contribute to the treatment cost.
The Center for Psychedelic and Consciousness Research at Johns Hopkins University has conducted extensive research into psilocybin as a treatment for depression, anxiety, and nicotine addiction.
Colorado and Oregon have also legalized psilocybin mushrooms, and a handful of other cities have passed local measures decriminalizing some psychedelics, including Denver and Washington, D.C.
